Karen Bernstein serves as Executive at Ovid Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Karen Bernstein has executed 3 insider transactions totaling $82.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 16, 2023 involved exercising options for 8,750 shares valued at $0.
Karen Bernstein currently holds 8,750 shares of Ovid Therapeutics Inc. (OVID), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Bernstein has been a net buyer of OVID stock. They have purchased $82.5K and sold $0 worth of shares.
Karen Bernstein's most recent insider trade was on Feb 16, 2023, when they sold 8,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.02 |
| Discretionary |
| Aug 14, 2018 | OVID | $62.3K | Purchase | 10,000 | $6.23 | Discretionary |